Stockreport

Cytek Biosciences Announces $50 Million Stock Repurchase Program

Cytek Biosciences, Inc.  (CTKB) 
PDF FREMONT, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of [Read more]